Results 331 to 340 of about 256,813 (405)

Clinical characteristics and outcome of human herpesvirus-6 encephalitis after allogeneic hematopoietic stem cell transplantation

Bone Marrow Transplantation, 2017
Masao Ogata, K. Oshima, T. Ikebe, K. Takano, H. Kanamori, T. Kondo, Yasunori Ueda, T. Mori, H. Hashimoto, H. Ogawa, T. Eto, T. Ueki, Toshihiro Miyamoto, T. Ichinohe, Y. Atsuta, T. Fukuda   +15 more
semanticscholar   +1 more source

Reduction in cord blood graft potency due to processing delay can be prevented by trehalose supplementation

Vox Sanguinis, EarlyView.
Abstract Background and Objectives Maximizing the potency of cord blood (CB) units (CBU) is a goal of all CB banks. Low transplant cell dose in CB transplantation is one of several contributors to the slower engraftment. Processing delays could also be at play because CBU can be stored at room temperature (RT) for up to 48 h before cryopreservation. We
Suria Jahan, Harinad B. Maganti, Jaina Patel, Roya Pasha, Emily Doxtator, Javed K. Manesia, Nicolas Pineault   +6 more
wiley   +1 more source

Successful treatment with refractory myasthenia gravis that developed after allogeneic hematopoietic stem cell transplantation: two case reports. [PDF]

Front Immunol
Zhang H, Wen Y, Ou Y, Chen X, Peng Y, Lai M, Mo W, Wang H.   +7 more
europepmc   +1 more source

Impact of pre‐transplant depression on outcomes of allogeneic and autologous hematopoietic stem cell transplantation

Cancer, 2017
A. El-Jawahri, Yi-Bin Chen, R. Brazauskas, N. He, Stephanie J. Lee, J. Knight, N. Majhail, D. Buchbinder, R. Schears, B. Wirk, W. Wood, I. Ahmed, M. Aljurf, J. Szer, S. Beattie, M. Battiwalla, C. Dandoy, M. Díaz, A. D’Souza, C. Freytes, J. Gajewski, U. Gergis, S. Hashmi, A. Jakubowski, R. Kamble, T. Kindwall‐Keller, H. M. Lazarus, Adriana K Malone, D. Marks, K. Meehan, B. Savani, R. Olsson, D. Rizzieri, A. Steinberg, D. Speckhart, D. Szwajcer, H. Schoemans, S. Seo, C. Ustun, Y. Atsuta, J. Dalal, Carmem Sales-Bonfim, N. Khera, T. Hahn, W. Saber   +44 more
semanticscholar   +1 more source

Determination of CD177 (human neutrophil antigen 2) polymorphisms using nanopore sequencing

Vox Sanguinis, EarlyView.
Abstract Background and Objectives Human neutrophil antigen 2 (HNA‐2), encoded by the CD177 gene, is considered one of the most important neutrophil antigens in human medicine, but molecular testing of CD177 is complicated and therefore not a standard procedure for investigating CD177 expression.
Kirstine Kløve‐Mogensen, Thure Mors Haunstrup, Anne‐Louise Fjordside Bilde, Rudi Steffensen   +3 more
wiley   +1 more source

Lack of Evidence Supporting a Significant Benefit of Pre-Transplant Consolidation Therapy in AML CR2 Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation. [PDF]

Cancers (Basel)
Lv M, Huang T, Mo XD, Sun YQ, Chang YJ, Xu LP, Zhang XH, Huang XJ, Wang Y.   +8 more
europepmc   +1 more source

Management of T‐cell malignancies: Bench‐to‐bedside targeting of epigenetic biology

CA: A Cancer Journal for Clinicians, EarlyView.
Abstract The peripheral T‐cell lymphomas (PTCL) are the only disease for which four histone deacetylase (HDAC) inhibitors have been approved globally as single agents. Although it is not clear why the PTCL exhibit such a vulnerability to these drugs, understanding the biological basis for this activity is essential.
Ariana Sabzevari, Johnson Ung, Jeffrey W. Craig, Kallesh D. Jayappa, Ipsita Pal, David J. Feith, Thomas P. Loughran Jr, Owen A. O’Connor   +7 more
wiley   +1 more source

Allogeneic hematopoietic stem cell transplantation for thalassemia major using matched unrelated donors and haploidentical related donors. [PDF]

Chin Med J (Engl)
Wang F, Qu Y, Jiang H.
europepmc   +1 more source

A liberalized diet does not improve caloric intake during neutropenia in patients undergoing hematopoietic stem cell transplants: A prospective randomized controlled trial

Nutrition in Clinical Practice, Volume 40, Issue 3, Page 584-595, June 2025.
Abstract Background The neutropenic diet has been a long‐standing approach to preventing infection in patients with hematopoietic stem cell transplants (HSCTs), although data on its efficacy are inconclusive and its restrictive nature might contribute to harm by reducing dietary intake in this patient population who typically experiences poor oral ...
Jenna N. Schulz, Kristina H. McGee, Michael T. Weaver, John R. Wingard, Precious D. Williams, Christina L. Cline, Nosha Farhadfar, Debra Lynch‐Kelly, Zeina A. Al‐Mansour, Wendy J. Dahl   +9 more
wiley   +1 more source

Viral Metagenomics in Patients Who Underwent Allogeneic Hematopoietic Stem Cell Transplantation (HSCT): A Brazilian Experience. [PDF]

Microorganisms
de Campos GM, de Mello Costa TC, Silveira RM, Valença IN, Bezerra RDS, Darrigo Junior LG, Vieira ACJ, Mesquita CC, Laurindo PDS, Cunha RG, Kashima S, Covas DT, Simões BP, Sampaio SC, Elias MC, Giovanetti M, Slavov SN.   +16 more
europepmc   +1 more source